Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 10, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 12, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001104659-26-126376
Filed / recorded
Nov 12, 2026, 11:54 PM UTC
Added to OQRO
Nov 12, 2026, 11:55 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
PALVELLA THERAPEUTICS, INC.
Issuer CIK
1583648
Ticker
PVLA
Reporting person
Jeffrey S Martini
Relationship
Officer
Officer title
Chief Scientific Officer
Security
Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Nov 10, 2026
Transaction code
M
Shares / units
1,984
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
26,770
Ownership form
Direct
Amendment
No
Footnotes from the filing
The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 13, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons.
The stock option vests in equal monthly installments over a forty-eight month period. The option was granted on February 23, 2023.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
